- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
834
Companies which are more than 50% undervalued based on analyst price target.
834 companies
Lytix Biopharma
Market Cap: NOK 382.3m
A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.
LYTIX
NOK 5.60
7D
3.7%
1Y
-2.8%
Xilio Therapeutics
Market Cap: US$36.8m
A clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies.
XLO
US$0.71
7D
-5.4%
1Y
-39.8%
SCYNEXIS
Market Cap: US$36.7m
A biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States.
SCYX
US$0.94
7D
-8.1%
1Y
-51.4%
Microbix Biosystems
Market Cap: CA$50.7m
A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
MBX
CA$0.36
7D
-8.9%
1Y
5.9%
Acrivon Therapeutics
Market Cap: US$36.4m
A clinical stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform.
ACRV
US$1.16
7D
-17.7%
1Y
-86.8%
Werewolf Therapeutics
Market Cap: US$35.9m
A biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.
HOWL
US$0.80
7D
-11.6%
1Y
-84.2%
Moberg Pharma
Market Cap: SEK 345.5m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 7.40
7D
-5.6%
1Y
-76.5%
Iterum Therapeutics
Market Cap: US$35.3m
A pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States.
ITRM
US$1.02
7D
-7.3%
1Y
-34.2%
Initiator Pharma
Market Cap: SEK 342.6m
A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.
INIT
SEK 6.10
7D
-4.1%
1Y
-33.7%
Futura Medical
Market Cap: UK£26.4m
Research, develops, and sells pharmaceutical and healthcare products for sexual health.
FUM
UK£0.087
7D
-2.8%
1Y
-78.1%
Barinthus Biotherapeutics
Market Cap: US$35.0m
A clinical-stage biopharmaceutical company, engages in development of novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer.
BRNS
US$0.87
7D
-4.9%
1Y
-62.9%
Spero Therapeutics
Market Cap: US$34.7m
A clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States.
SPRO
US$0.62
7D
-4.2%
1Y
-62.2%
NRx Pharmaceuticals
Market Cap: US$34.5m
A clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain.
NRXP
US$2.04
7D
-0.7%
1Y
-32.9%
bluebird bio
Market Cap: US$34.3m
A biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States.
BLUE
US$3.50
7D
-11.4%
1Y
-83.5%
Ayr Wellness
Market Cap: CA$47.0m
Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods.
AYR.A
CA$0.39
7D
-14.4%
1Y
-88.4%
Vidac Pharma Holding
Market Cap: €29.9m
An investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases.
T9G
€0.58
7D
0%
1Y
202.1%
Shield Therapeutics
Market Cap: UK£25.0m
A commercial stage specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs.
STX
UK£0.024
7D
0%
1Y
26.3%
Lipum
Market Cap: SEK 319.2m
A biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden.
LIPUM
SEK 15.05
7D
-2.0%
1Y
129.8%
Boundless Bio
Market Cap: US$32.2m
A clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA).
BOLD
US$1.44
7D
-10.3%
1Y
-83.2%
Dyadic International
Market Cap: US$32.2m
A biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally.
DYAI
US$1.07
7D
-10.8%
1Y
-26.2%
Radiopharm Theranostics
Market Cap: AU$50.2m
Engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs.
RAD
AU$0.021
7D
-6.5%
1Y
-46.3%
GenSight Biologics
Market Cap: €28.5m
A clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.
SIGHT
€0.22
7D
-4.2%
1Y
-46.3%
Xbrane Biopharma
Market Cap: SEK 311.3m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.20
7D
6.2%
1Y
-11.5%
FibroBiologics
Market Cap: US$31.8m
Operates as a cell therapy, regenerative medicine company.
FBLG
US$0.83
7D
-17.8%
1Y
-91.1%
FibroGen
Market Cap: US$31.1m
A biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.
FGEN
US$0.31
7D
-7.6%
1Y
-73.4%
Kezar Life Sciences
Market Cap: US$30.8m
A clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States.
KZR
US$4.22
7D
-6.2%
1Y
-45.4%
Mendus
Market Cap: SEK 291.1m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 5.78
7D
9.3%
1Y
-37.0%
Annovis Bio
Market Cap: US$29.8m
A clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States.
ANVS
US$1.53
7D
-5.0%
1Y
-74.2%
CASI Pharmaceuticals
Market Cap: US$29.2m
A biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People’s Republic of China, the United States, and internationally.
CASI
US$1.89
7D
-3.3%
1Y
-28.9%
Decibel Cannabis
Market Cap: CA$40.4m
An integrated cannabis company, engages in the cannabis cultivation in Canada.
DB
CA$0.07
7D
7.7%
1Y
-41.7%
Guard Therapeutics International
Market Cap: SEK 280.3m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 13.90
7D
1.1%
1Y
-57.9%
PolyPid
Market Cap: US$28.2m
A clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs.
PYPD
US$2.77
7D
-0.7%
1Y
-41.6%
MiNK Therapeutics
Market Cap: US$27.9m
A clinical-stage biopharmaceutical company, engages in the discovery, development, manufacture, and commercialization of allogeneic, off-the-shelf, and invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases.
INKT
US$7.03
7D
-7.5%
1Y
-21.9%
Cynata Therapeutics
Market Cap: AU$42.9m
Engages in the development and commercialization of proprietary induced pluripotent stem cell and mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia.
CYP
AU$0.19
7D
-2.6%
1Y
-15.6%
Aligos Therapeutics
Market Cap: US$27.4m
A clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in viral and liver diseases.
ALGS
US$4.48
7D
-20.0%
1Y
-75.5%
Cadrenal Therapeutics
Market Cap: US$27.2m
Operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions.
CVKD
US$14.45
7D
-12.2%
1Y
109.4%